Mild COVID-19 induces lasting antibody protection, study finds
The Hindu
The researchers found antibody-producing cells in people 11 months after first symptoms.
Months after recovering from mild cases of COVID-19, people still have immune cells which produce antibodies against the novel coronavirus, . The researchers from Washington University School of Medicine in St. Louis, U.S., noted that such cells could persist for a lifetime, churning out antibodies all the while. The study, published on Monday in the journal Nature, suggests that mild cases of COVID-19 leave those infected with lasting antibody protection and that repeated bouts of illness are likely to be uncommon.More Related News

After more-than-two-year wait, the flyover at Goripalayam junction will be commissioned on Saturday. As of now, the main arm of the new flyover, named after freedom fighter Netaji Subash Chandra Bose, will help to decongest vehicular movement from Tamukkam junction till Nelpettai junction on East Veli Street.












